Healthcare provider profile · identity verified

Frank David Fidler, ARNP

Nurse Practitioner · TAMPA, FL · NPI 1508968488

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Atorvastatin Calcium	Atorvastatin Calcium	390	59
Furosemide	Furosemide	333	50
Amlodipine Besylate	Amlodipine Besylate	275	41
Levothyroxine Sodium	Levothyroxine Sodium	227	37
Metoprolol Tartrate	Metoprolol Tartrate	222	33
Donepezil Hcl	Donepezil Hcl	202	29
Gabapentin	Gabapentin	199	29
Potassium Chloride	Potassium Chloride	198	36
Memantine Hcl	Memantine Hcl	196	29
Eliquis	Apixaban	181	24
Omeprazole	Omeprazole	179	26
Tamsulosin Hcl	Tamsulosin Hcl	163	26
Pantoprazole Sodium	Pantoprazole Sodium	159	25
Lisinopril	Lisinopril	152	28
Metformin Hcl	Metformin Hcl	140	20
Tramadol Hcl	Tramadol Hcl	136	36
Mirtazapine	Mirtazapine	126	25
Losartan Potassium	Losartan Potassium	125	20
Famotidine	Famotidine	112	16
Simvastatin	Simvastatin	112	21
Quetiapine Fumarate	Quetiapine Fumarate	99	17
Carvedilol	Carvedilol	91	15
Rosuvastatin Calcium	Rosuvastatin Calcium	91	13
Trazodone Hcl	Trazodone Hcl	87	21
Duloxetine Hcl	Duloxetine Hcl	83	12
Warfarin Sodium	Warfarin Sodium	82	suppressed
Glipizide	Glipizide	79	12
Levetiracetam	Levetiracetam	73	11
Divalproex Sodium	Divalproex Sodium	72	16
Escitalopram Oxalate	Escitalopram Oxalate	70	16
Pregabalin	Pregabalin	70	suppressed
Finasteride	Finasteride	68	suppressed
Clonazepam	Clonazepam	66	suppressed
Clopidogrel	Clopidogrel Bisulfate	66	11
Fluticasone Propionate	Fluticasone Propionate	65	19
Citalopram Hbr	Citalopram Hydrobromide	64	suppressed
Lactulose	Lactulose	63	13
Metoprolol Succinate	Metoprolol Succinate	63	14
Albuterol Sulfate Hfa	Albuterol Sulfate	60	17
Levocetirizine Dihydrochloride	Levocetirizine Dihydrochloride	60	suppressed
Montelukast Sodium	Montelukast Sodium	58	12
Sertraline Hcl	Sertraline Hcl	58	11
Meloxicam	Meloxicam	57	suppressed
Loperamide	Loperamide Hcl	56	27
Ciprofloxacin Hcl	Ciprofloxacin Hcl	52	39
Latanoprost	Latanoprost	52	12
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	52	26
Buspirone Hcl	Buspirone Hcl	49	13
Glimepiride	Glimepiride	48	suppressed
Alprazolam	Alprazolam	47	11
Bumetanide	Bumetanide	47	suppressed
Primidone	Primidone	47	suppressed
Pravastatin Sodium	Pravastatin Sodium	45	suppressed
Nifedipine Er	Nifedipine	44	suppressed
Hydrochlorothiazide	Hydrochlorothiazide	40	suppressed
Allopurinol	Allopurinol	39	suppressed
Baclofen	Baclofen	39	suppressed
Benztropine Mesylate	Benztropine Mesylate	39	suppressed
Carbidopa-Levodopa	Carbidopa/Levodopa	37	suppressed
Autoshield Duo Pen Needle	Pen Needle,dual Safety,diabetc	36	12
Januvia	Sitagliptin Phosphate	36	suppressed
Lovastatin	Lovastatin	35	suppressed
Timolol Maleate	Timolol Maleate	35	suppressed
Enalapril Maleate	Enalapril Maleate	34	suppressed
Lamotrigine	Lamotrigine	34	suppressed
Nystatin	Nystatin	34	23
Pioglitazone Hcl	Pioglitazone Hcl	34	suppressed
Paroxetine Hcl	Paroxetine Hcl	33	suppressed
Propranolol Hcl	Propranolol Hcl	33	suppressed
Azithromycin	Azithromycin	32	26
Zolpidem Tartrate	Zolpidem Tartrate	32	suppressed
Sucralfate	Sucralfate	29	suppressed
Amiodarone Hcl	Amiodarone Hcl	27	suppressed
Hydralazine Hcl	Hydralazine Hcl	26	suppressed
Midodrine Hcl	Midodrine Hcl	26	suppressed
Oxybutynin Chloride	Oxybutynin Chloride	26	suppressed
Pramipexole Dihydrochloride	Pramipexole Di-Hcl	26	suppressed
Temazepam	Temazepam	26	suppressed
Nitrofurantoin	Nitrofurantoin Macrocrystal	25	suppressed
Lantus Solostar	Insulin Glargine,hum.Rec.Anlog	24	suppressed
Diclofenac Sodium	Diclofenac Sodium	23	suppressed
Hydroxyzine Hcl	Hydroxyzine Hcl	23	suppressed
Jardiance	Empagliflozin	23	suppressed
Farxiga	Dapagliflozin Propanediol	22	suppressed
Xarelto	Rivaroxaban	22	suppressed
Glipizide Er	Glipizide	21	suppressed
Topiramate	Topiramate	21	suppressed
Alendronate Sodium	Alendronate Sodium	20	suppressed
Ezetimibe	Ezetimibe	20	suppressed
Lorazepam	Lorazepam	20	suppressed
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	20	19
Meclizine Hcl	Meclizine Hcl	19	suppressed
Clonidine	Clonidine	18	suppressed
Methenamine Hippurate	Methenamine Hippurate	18	suppressed
Oxybutynin Chloride Er	Oxybutynin Chloride	18	suppressed
Levemir Flexpen	Insulin Detemir	17	suppressed
Omega-3 Acid Ethyl Esters	Omega-3 Acid Ethyl Esters	17	suppressed
Valsartan	Valsartan	17	suppressed
Zonisamide	Zonisamide	17	suppressed
Basaglar Kwikpen U-100	Insulin Glargine,hum.Rec.Anlog	16	suppressed
Carbamazepine Er	Carbamazepine	16	suppressed
Clindamycin Hcl	Clindamycin Hcl	16	14
Ibuprofen	Ibuprofen	16	suppressed
Isosorbide Mononitrate Er	Isosorbide Mononitrate	16	suppressed
Nitroglycerin	Nitroglycerin	16	suppressed
Ondansetron Hcl	Ondansetron Hcl	16	suppressed
Pentoxifylline	Pentoxifylline	16	suppressed
Lidocaine	Lidocaine	15	suppressed
Silodosin	Silodosin	15	suppressed
Vascepa	Icosapent Ethyl	15	suppressed
Vitamin D2	Ergocalciferol (Vitamin D2)	15	suppressed
Clonidine Hcl	Clonidine Hcl	14	suppressed
Niacin Er	Niacin	14	suppressed
Amantadine	Amantadine Hcl	13	suppressed
Cilostazol	Cilostazol	13	suppressed
Mexiletine Hcl	Mexiletine Hcl	13	suppressed
Olanzapine	Olanzapine	13	suppressed
Alfuzosin Hcl Er	Alfuzosin Hcl	12	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	12	11
Breo Ellipta	Fluticasone/Vilanterol	12	suppressed
Myrbetriq	Mirabegron	12	suppressed
Phenytoin Sodium Extended	Phenytoin Sodium Extended	12	suppressed
Risperidone	Risperidone	12	suppressed
Trulicity	Dulaglutide	12	suppressed
Cefdinir	Cefdinir	11	11
Esomeprazole Magnesium	Esomeprazole Magnesium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error